Medical Care
Global AI Biomedicine Service Market Research Report 2025
- Mar 27, 25
- ID: 162070
- Pages: 98
- Figures: 94
- Views: 42
The global market for AI Biomedicine Service was valued at US$ 1617 million in the year 2024 and is projected to reach a revised size of US$ 2265 million by 2031, growing at a CAGR of 5.7% during the forecast period.
AI biomedicine service represents the deep application of artificial intelligence technology in the biomedical field, aiming to accelerate new drug development, optimize disease diagnosis and treatment plans through advanced technologies such as big data analysis and machine learning. This service encompasses multiple aspects, from drug discovery and clinical trial design to patient management, significantly improving the efficiency and accuracy of biomedical research and development. By deeply mining massive medical data, ai can identify potential biomarkers, predict disease progression, and provide personalized treatment plans for patients. Additionally, ai assists doctors in diagnosing complex diseases, reducing misdiagnosis rates, and enhancing the quality of medical services. With continuous technological advancements, ai biomedicine service is gradually transforming the landscape of the biomedical industry, bringing more health benefits to patients.
North American market for AI Biomedicine Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI Biomedicine Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for AI Biomedicine Service in Oral Preparations is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI Biomedicine Service include Abcellera Biologics, HotSpot Therapeutics, C4XD Discovery, Thorne HealthTech, Scorpion Therapeutics, Charm Therapeutics, Evisagenics, Evotec, PathAI, Wave Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI Biomedicine Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Biomedicine Service.
The AI Biomedicine Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Biomedicine Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Biomedicine Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcellera Biologics
HotSpot Therapeutics
C4XD Discovery
Thorne HealthTech
Scorpion Therapeutics
Charm Therapeutics
Evisagenics
Evotec
PathAI
Wave Life Sciences
LifeMine Therapeutics
PaigeAI
Westlake Omics
Atomwise
XtalPi
IIpharma
Segment by Type
AI Biomedical Research And Development
AI Biomedical Commercialization License
Segment by Application
Oral Preparations
Injections
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Biomedicine Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
AI biomedicine service represents the deep application of artificial intelligence technology in the biomedical field, aiming to accelerate new drug development, optimize disease diagnosis and treatment plans through advanced technologies such as big data analysis and machine learning. This service encompasses multiple aspects, from drug discovery and clinical trial design to patient management, significantly improving the efficiency and accuracy of biomedical research and development. By deeply mining massive medical data, ai can identify potential biomarkers, predict disease progression, and provide personalized treatment plans for patients. Additionally, ai assists doctors in diagnosing complex diseases, reducing misdiagnosis rates, and enhancing the quality of medical services. With continuous technological advancements, ai biomedicine service is gradually transforming the landscape of the biomedical industry, bringing more health benefits to patients.
North American market for AI Biomedicine Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI Biomedicine Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for AI Biomedicine Service in Oral Preparations is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI Biomedicine Service include Abcellera Biologics, HotSpot Therapeutics, C4XD Discovery, Thorne HealthTech, Scorpion Therapeutics, Charm Therapeutics, Evisagenics, Evotec, PathAI, Wave Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI Biomedicine Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Biomedicine Service.
The AI Biomedicine Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Biomedicine Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Biomedicine Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcellera Biologics
HotSpot Therapeutics
C4XD Discovery
Thorne HealthTech
Scorpion Therapeutics
Charm Therapeutics
Evisagenics
Evotec
PathAI
Wave Life Sciences
LifeMine Therapeutics
PaigeAI
Westlake Omics
Atomwise
XtalPi
IIpharma
Segment by Type
AI Biomedical Research And Development
AI Biomedical Commercialization License
Segment by Application
Oral Preparations
Injections
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Biomedicine Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Biomedicine Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AI Biomedical Research And Development
1.2.3 AI Biomedical Commercialization License
1.3 Market by Application
1.3.1 Global AI Biomedicine Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral Preparations
1.3.3 Injections
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Biomedicine Service Market Perspective (2020-2031)
2.2 Global AI Biomedicine Service Growth Trends by Region
2.2.1 Global AI Biomedicine Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI Biomedicine Service Historic Market Size by Region (2020-2025)
2.2.3 AI Biomedicine Service Forecasted Market Size by Region (2026-2031)
2.3 AI Biomedicine Service Market Dynamics
2.3.1 AI Biomedicine Service Industry Trends
2.3.2 AI Biomedicine Service Market Drivers
2.3.3 AI Biomedicine Service Market Challenges
2.3.4 AI Biomedicine Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Biomedicine Service Players by Revenue
3.1.1 Global Top AI Biomedicine Service Players by Revenue (2020-2025)
3.1.2 Global AI Biomedicine Service Revenue Market Share by Players (2020-2025)
3.2 Global Top AI Biomedicine Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI Biomedicine Service Revenue
3.4 Global AI Biomedicine Service Market Concentration Ratio
3.4.1 Global AI Biomedicine Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Biomedicine Service Revenue in 2024
3.5 Global Key Players of AI Biomedicine Service Head office and Area Served
3.6 Global Key Players of AI Biomedicine Service, Product and Application
3.7 Global Key Players of AI Biomedicine Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Biomedicine Service Breakdown Data by Type
4.1 Global AI Biomedicine Service Historic Market Size by Type (2020-2025)
4.2 Global AI Biomedicine Service Forecasted Market Size by Type (2026-2031)
5 AI Biomedicine Service Breakdown Data by Application
5.1 Global AI Biomedicine Service Historic Market Size by Application (2020-2025)
5.2 Global AI Biomedicine Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI Biomedicine Service Market Size (2020-2031)
6.2 North America AI Biomedicine Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI Biomedicine Service Market Size by Country (2020-2025)
6.4 North America AI Biomedicine Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Biomedicine Service Market Size (2020-2031)
7.2 Europe AI Biomedicine Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI Biomedicine Service Market Size by Country (2020-2025)
7.4 Europe AI Biomedicine Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Biomedicine Service Market Size (2020-2031)
8.2 Asia-Pacific AI Biomedicine Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI Biomedicine Service Market Size by Region (2020-2025)
8.4 Asia-Pacific AI Biomedicine Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Biomedicine Service Market Size (2020-2031)
9.2 Latin America AI Biomedicine Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI Biomedicine Service Market Size by Country (2020-2025)
9.4 Latin America AI Biomedicine Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Biomedicine Service Market Size (2020-2031)
10.2 Middle East & Africa AI Biomedicine Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI Biomedicine Service Market Size by Country (2020-2025)
10.4 Middle East & Africa AI Biomedicine Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcellera Biologics
11.1.1 Abcellera Biologics Company Details
11.1.2 Abcellera Biologics Business Overview
11.1.3 Abcellera Biologics AI Biomedicine Service Introduction
11.1.4 Abcellera Biologics Revenue in AI Biomedicine Service Business (2020-2025)
11.1.5 Abcellera Biologics Recent Development
11.2 HotSpot Therapeutics
11.2.1 HotSpot Therapeutics Company Details
11.2.2 HotSpot Therapeutics Business Overview
11.2.3 HotSpot Therapeutics AI Biomedicine Service Introduction
11.2.4 HotSpot Therapeutics Revenue in AI Biomedicine Service Business (2020-2025)
11.2.5 HotSpot Therapeutics Recent Development
11.3 C4XD Discovery
11.3.1 C4XD Discovery Company Details
11.3.2 C4XD Discovery Business Overview
11.3.3 C4XD Discovery AI Biomedicine Service Introduction
11.3.4 C4XD Discovery Revenue in AI Biomedicine Service Business (2020-2025)
11.3.5 C4XD Discovery Recent Development
11.4 Thorne HealthTech
11.4.1 Thorne HealthTech Company Details
11.4.2 Thorne HealthTech Business Overview
11.4.3 Thorne HealthTech AI Biomedicine Service Introduction
11.4.4 Thorne HealthTech Revenue in AI Biomedicine Service Business (2020-2025)
11.4.5 Thorne HealthTech Recent Development
11.5 Scorpion Therapeutics
11.5.1 Scorpion Therapeutics Company Details
11.5.2 Scorpion Therapeutics Business Overview
11.5.3 Scorpion Therapeutics AI Biomedicine Service Introduction
11.5.4 Scorpion Therapeutics Revenue in AI Biomedicine Service Business (2020-2025)
11.5.5 Scorpion Therapeutics Recent Development
11.6 Charm Therapeutics
11.6.1 Charm Therapeutics Company Details
11.6.2 Charm Therapeutics Business Overview
11.6.3 Charm Therapeutics AI Biomedicine Service Introduction
11.6.4 Charm Therapeutics Revenue in AI Biomedicine Service Business (2020-2025)
11.6.5 Charm Therapeutics Recent Development
11.7 Evisagenics
11.7.1 Evisagenics Company Details
11.7.2 Evisagenics Business Overview
11.7.3 Evisagenics AI Biomedicine Service Introduction
11.7.4 Evisagenics Revenue in AI Biomedicine Service Business (2020-2025)
11.7.5 Evisagenics Recent Development
11.8 Evotec
11.8.1 Evotec Company Details
11.8.2 Evotec Business Overview
11.8.3 Evotec AI Biomedicine Service Introduction
11.8.4 Evotec Revenue in AI Biomedicine Service Business (2020-2025)
11.8.5 Evotec Recent Development
11.9 PathAI
11.9.1 PathAI Company Details
11.9.2 PathAI Business Overview
11.9.3 PathAI AI Biomedicine Service Introduction
11.9.4 PathAI Revenue in AI Biomedicine Service Business (2020-2025)
11.9.5 PathAI Recent Development
11.10 Wave Life Sciences
11.10.1 Wave Life Sciences Company Details
11.10.2 Wave Life Sciences Business Overview
11.10.3 Wave Life Sciences AI Biomedicine Service Introduction
11.10.4 Wave Life Sciences Revenue in AI Biomedicine Service Business (2020-2025)
11.10.5 Wave Life Sciences Recent Development
11.11 LifeMine Therapeutics
11.11.1 LifeMine Therapeutics Company Details
11.11.2 LifeMine Therapeutics Business Overview
11.11.3 LifeMine Therapeutics AI Biomedicine Service Introduction
11.11.4 LifeMine Therapeutics Revenue in AI Biomedicine Service Business (2020-2025)
11.11.5 LifeMine Therapeutics Recent Development
11.12 PaigeAI
11.12.1 PaigeAI Company Details
11.12.2 PaigeAI Business Overview
11.12.3 PaigeAI AI Biomedicine Service Introduction
11.12.4 PaigeAI Revenue in AI Biomedicine Service Business (2020-2025)
11.12.5 PaigeAI Recent Development
11.13 Westlake Omics
11.13.1 Westlake Omics Company Details
11.13.2 Westlake Omics Business Overview
11.13.3 Westlake Omics AI Biomedicine Service Introduction
11.13.4 Westlake Omics Revenue in AI Biomedicine Service Business (2020-2025)
11.13.5 Westlake Omics Recent Development
11.14 Atomwise
11.14.1 Atomwise Company Details
11.14.2 Atomwise Business Overview
11.14.3 Atomwise AI Biomedicine Service Introduction
11.14.4 Atomwise Revenue in AI Biomedicine Service Business (2020-2025)
11.14.5 Atomwise Recent Development
11.15 XtalPi
11.15.1 XtalPi Company Details
11.15.2 XtalPi Business Overview
11.15.3 XtalPi AI Biomedicine Service Introduction
11.15.4 XtalPi Revenue in AI Biomedicine Service Business (2020-2025)
11.15.5 XtalPi Recent Development
11.16 IIpharma
11.16.1 IIpharma Company Details
11.16.2 IIpharma Business Overview
11.16.3 IIpharma AI Biomedicine Service Introduction
11.16.4 IIpharma Revenue in AI Biomedicine Service Business (2020-2025)
11.16.5 IIpharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Biomedicine Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AI Biomedical Research And Development
1.2.3 AI Biomedical Commercialization License
1.3 Market by Application
1.3.1 Global AI Biomedicine Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral Preparations
1.3.3 Injections
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Biomedicine Service Market Perspective (2020-2031)
2.2 Global AI Biomedicine Service Growth Trends by Region
2.2.1 Global AI Biomedicine Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI Biomedicine Service Historic Market Size by Region (2020-2025)
2.2.3 AI Biomedicine Service Forecasted Market Size by Region (2026-2031)
2.3 AI Biomedicine Service Market Dynamics
2.3.1 AI Biomedicine Service Industry Trends
2.3.2 AI Biomedicine Service Market Drivers
2.3.3 AI Biomedicine Service Market Challenges
2.3.4 AI Biomedicine Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Biomedicine Service Players by Revenue
3.1.1 Global Top AI Biomedicine Service Players by Revenue (2020-2025)
3.1.2 Global AI Biomedicine Service Revenue Market Share by Players (2020-2025)
3.2 Global Top AI Biomedicine Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI Biomedicine Service Revenue
3.4 Global AI Biomedicine Service Market Concentration Ratio
3.4.1 Global AI Biomedicine Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Biomedicine Service Revenue in 2024
3.5 Global Key Players of AI Biomedicine Service Head office and Area Served
3.6 Global Key Players of AI Biomedicine Service, Product and Application
3.7 Global Key Players of AI Biomedicine Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Biomedicine Service Breakdown Data by Type
4.1 Global AI Biomedicine Service Historic Market Size by Type (2020-2025)
4.2 Global AI Biomedicine Service Forecasted Market Size by Type (2026-2031)
5 AI Biomedicine Service Breakdown Data by Application
5.1 Global AI Biomedicine Service Historic Market Size by Application (2020-2025)
5.2 Global AI Biomedicine Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI Biomedicine Service Market Size (2020-2031)
6.2 North America AI Biomedicine Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI Biomedicine Service Market Size by Country (2020-2025)
6.4 North America AI Biomedicine Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Biomedicine Service Market Size (2020-2031)
7.2 Europe AI Biomedicine Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI Biomedicine Service Market Size by Country (2020-2025)
7.4 Europe AI Biomedicine Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Biomedicine Service Market Size (2020-2031)
8.2 Asia-Pacific AI Biomedicine Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI Biomedicine Service Market Size by Region (2020-2025)
8.4 Asia-Pacific AI Biomedicine Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Biomedicine Service Market Size (2020-2031)
9.2 Latin America AI Biomedicine Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI Biomedicine Service Market Size by Country (2020-2025)
9.4 Latin America AI Biomedicine Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Biomedicine Service Market Size (2020-2031)
10.2 Middle East & Africa AI Biomedicine Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI Biomedicine Service Market Size by Country (2020-2025)
10.4 Middle East & Africa AI Biomedicine Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcellera Biologics
11.1.1 Abcellera Biologics Company Details
11.1.2 Abcellera Biologics Business Overview
11.1.3 Abcellera Biologics AI Biomedicine Service Introduction
11.1.4 Abcellera Biologics Revenue in AI Biomedicine Service Business (2020-2025)
11.1.5 Abcellera Biologics Recent Development
11.2 HotSpot Therapeutics
11.2.1 HotSpot Therapeutics Company Details
11.2.2 HotSpot Therapeutics Business Overview
11.2.3 HotSpot Therapeutics AI Biomedicine Service Introduction
11.2.4 HotSpot Therapeutics Revenue in AI Biomedicine Service Business (2020-2025)
11.2.5 HotSpot Therapeutics Recent Development
11.3 C4XD Discovery
11.3.1 C4XD Discovery Company Details
11.3.2 C4XD Discovery Business Overview
11.3.3 C4XD Discovery AI Biomedicine Service Introduction
11.3.4 C4XD Discovery Revenue in AI Biomedicine Service Business (2020-2025)
11.3.5 C4XD Discovery Recent Development
11.4 Thorne HealthTech
11.4.1 Thorne HealthTech Company Details
11.4.2 Thorne HealthTech Business Overview
11.4.3 Thorne HealthTech AI Biomedicine Service Introduction
11.4.4 Thorne HealthTech Revenue in AI Biomedicine Service Business (2020-2025)
11.4.5 Thorne HealthTech Recent Development
11.5 Scorpion Therapeutics
11.5.1 Scorpion Therapeutics Company Details
11.5.2 Scorpion Therapeutics Business Overview
11.5.3 Scorpion Therapeutics AI Biomedicine Service Introduction
11.5.4 Scorpion Therapeutics Revenue in AI Biomedicine Service Business (2020-2025)
11.5.5 Scorpion Therapeutics Recent Development
11.6 Charm Therapeutics
11.6.1 Charm Therapeutics Company Details
11.6.2 Charm Therapeutics Business Overview
11.6.3 Charm Therapeutics AI Biomedicine Service Introduction
11.6.4 Charm Therapeutics Revenue in AI Biomedicine Service Business (2020-2025)
11.6.5 Charm Therapeutics Recent Development
11.7 Evisagenics
11.7.1 Evisagenics Company Details
11.7.2 Evisagenics Business Overview
11.7.3 Evisagenics AI Biomedicine Service Introduction
11.7.4 Evisagenics Revenue in AI Biomedicine Service Business (2020-2025)
11.7.5 Evisagenics Recent Development
11.8 Evotec
11.8.1 Evotec Company Details
11.8.2 Evotec Business Overview
11.8.3 Evotec AI Biomedicine Service Introduction
11.8.4 Evotec Revenue in AI Biomedicine Service Business (2020-2025)
11.8.5 Evotec Recent Development
11.9 PathAI
11.9.1 PathAI Company Details
11.9.2 PathAI Business Overview
11.9.3 PathAI AI Biomedicine Service Introduction
11.9.4 PathAI Revenue in AI Biomedicine Service Business (2020-2025)
11.9.5 PathAI Recent Development
11.10 Wave Life Sciences
11.10.1 Wave Life Sciences Company Details
11.10.2 Wave Life Sciences Business Overview
11.10.3 Wave Life Sciences AI Biomedicine Service Introduction
11.10.4 Wave Life Sciences Revenue in AI Biomedicine Service Business (2020-2025)
11.10.5 Wave Life Sciences Recent Development
11.11 LifeMine Therapeutics
11.11.1 LifeMine Therapeutics Company Details
11.11.2 LifeMine Therapeutics Business Overview
11.11.3 LifeMine Therapeutics AI Biomedicine Service Introduction
11.11.4 LifeMine Therapeutics Revenue in AI Biomedicine Service Business (2020-2025)
11.11.5 LifeMine Therapeutics Recent Development
11.12 PaigeAI
11.12.1 PaigeAI Company Details
11.12.2 PaigeAI Business Overview
11.12.3 PaigeAI AI Biomedicine Service Introduction
11.12.4 PaigeAI Revenue in AI Biomedicine Service Business (2020-2025)
11.12.5 PaigeAI Recent Development
11.13 Westlake Omics
11.13.1 Westlake Omics Company Details
11.13.2 Westlake Omics Business Overview
11.13.3 Westlake Omics AI Biomedicine Service Introduction
11.13.4 Westlake Omics Revenue in AI Biomedicine Service Business (2020-2025)
11.13.5 Westlake Omics Recent Development
11.14 Atomwise
11.14.1 Atomwise Company Details
11.14.2 Atomwise Business Overview
11.14.3 Atomwise AI Biomedicine Service Introduction
11.14.4 Atomwise Revenue in AI Biomedicine Service Business (2020-2025)
11.14.5 Atomwise Recent Development
11.15 XtalPi
11.15.1 XtalPi Company Details
11.15.2 XtalPi Business Overview
11.15.3 XtalPi AI Biomedicine Service Introduction
11.15.4 XtalPi Revenue in AI Biomedicine Service Business (2020-2025)
11.15.5 XtalPi Recent Development
11.16 IIpharma
11.16.1 IIpharma Company Details
11.16.2 IIpharma Business Overview
11.16.3 IIpharma AI Biomedicine Service Introduction
11.16.4 IIpharma Revenue in AI Biomedicine Service Business (2020-2025)
11.16.5 IIpharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI Biomedicine Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AI Biomedical Research And Development
Table 3. Key Players of AI Biomedical Commercialization License
Table 4. Global AI Biomedicine Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global AI Biomedicine Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global AI Biomedicine Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global AI Biomedicine Service Market Share by Region (2020-2025)
Table 8. Global AI Biomedicine Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global AI Biomedicine Service Market Share by Region (2026-2031)
Table 10. AI Biomedicine Service Market Trends
Table 11. AI Biomedicine Service Market Drivers
Table 12. AI Biomedicine Service Market Challenges
Table 13. AI Biomedicine Service Market Restraints
Table 14. Global AI Biomedicine Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global AI Biomedicine Service Market Share by Players (2020-2025)
Table 16. Global Top AI Biomedicine Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Biomedicine Service as of 2024)
Table 17. Ranking of Global Top AI Biomedicine Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by AI Biomedicine Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of AI Biomedicine Service, Headquarters and Area Served
Table 20. Global Key Players of AI Biomedicine Service, Product and Application
Table 21. Global Key Players of AI Biomedicine Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global AI Biomedicine Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global AI Biomedicine Service Revenue Market Share by Type (2020-2025)
Table 25. Global AI Biomedicine Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global AI Biomedicine Service Revenue Market Share by Type (2026-2031)
Table 27. Global AI Biomedicine Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global AI Biomedicine Service Revenue Market Share by Application (2020-2025)
Table 29. Global AI Biomedicine Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global AI Biomedicine Service Revenue Market Share by Application (2026-2031)
Table 31. North America AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America AI Biomedicine Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America AI Biomedicine Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe AI Biomedicine Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe AI Biomedicine Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific AI Biomedicine Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific AI Biomedicine Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific AI Biomedicine Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America AI Biomedicine Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America AI Biomedicine Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa AI Biomedicine Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa AI Biomedicine Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abcellera Biologics Company Details
Table 47. Abcellera Biologics Business Overview
Table 48. Abcellera Biologics AI Biomedicine Service Product
Table 49. Abcellera Biologics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 50. Abcellera Biologics Recent Development
Table 51. HotSpot Therapeutics Company Details
Table 52. HotSpot Therapeutics Business Overview
Table 53. HotSpot Therapeutics AI Biomedicine Service Product
Table 54. HotSpot Therapeutics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 55. HotSpot Therapeutics Recent Development
Table 56. C4XD Discovery Company Details
Table 57. C4XD Discovery Business Overview
Table 58. C4XD Discovery AI Biomedicine Service Product
Table 59. C4XD Discovery Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 60. C4XD Discovery Recent Development
Table 61. Thorne HealthTech Company Details
Table 62. Thorne HealthTech Business Overview
Table 63. Thorne HealthTech AI Biomedicine Service Product
Table 64. Thorne HealthTech Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 65. Thorne HealthTech Recent Development
Table 66. Scorpion Therapeutics Company Details
Table 67. Scorpion Therapeutics Business Overview
Table 68. Scorpion Therapeutics AI Biomedicine Service Product
Table 69. Scorpion Therapeutics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 70. Scorpion Therapeutics Recent Development
Table 71. Charm Therapeutics Company Details
Table 72. Charm Therapeutics Business Overview
Table 73. Charm Therapeutics AI Biomedicine Service Product
Table 74. Charm Therapeutics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 75. Charm Therapeutics Recent Development
Table 76. Evisagenics Company Details
Table 77. Evisagenics Business Overview
Table 78. Evisagenics AI Biomedicine Service Product
Table 79. Evisagenics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 80. Evisagenics Recent Development
Table 81. Evotec Company Details
Table 82. Evotec Business Overview
Table 83. Evotec AI Biomedicine Service Product
Table 84. Evotec Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 85. Evotec Recent Development
Table 86. PathAI Company Details
Table 87. PathAI Business Overview
Table 88. PathAI AI Biomedicine Service Product
Table 89. PathAI Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 90. PathAI Recent Development
Table 91. Wave Life Sciences Company Details
Table 92. Wave Life Sciences Business Overview
Table 93. Wave Life Sciences AI Biomedicine Service Product
Table 94. Wave Life Sciences Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 95. Wave Life Sciences Recent Development
Table 96. LifeMine Therapeutics Company Details
Table 97. LifeMine Therapeutics Business Overview
Table 98. LifeMine Therapeutics AI Biomedicine Service Product
Table 99. LifeMine Therapeutics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 100. LifeMine Therapeutics Recent Development
Table 101. PaigeAI Company Details
Table 102. PaigeAI Business Overview
Table 103. PaigeAI AI Biomedicine Service Product
Table 104. PaigeAI Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 105. PaigeAI Recent Development
Table 106. Westlake Omics Company Details
Table 107. Westlake Omics Business Overview
Table 108. Westlake Omics AI Biomedicine Service Product
Table 109. Westlake Omics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 110. Westlake Omics Recent Development
Table 111. Atomwise Company Details
Table 112. Atomwise Business Overview
Table 113. Atomwise AI Biomedicine Service Product
Table 114. Atomwise Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 115. Atomwise Recent Development
Table 116. XtalPi Company Details
Table 117. XtalPi Business Overview
Table 118. XtalPi AI Biomedicine Service Product
Table 119. XtalPi Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 120. XtalPi Recent Development
Table 121. IIpharma Company Details
Table 122. IIpharma Business Overview
Table 123. IIpharma AI Biomedicine Service Product
Table 124. IIpharma Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 125. IIpharma Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. AI Biomedicine Service Picture
Figure 2. Global AI Biomedicine Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI Biomedicine Service Market Share by Type: 2024 VS 2031
Figure 4. AI Biomedical Research And Development Features
Figure 5. AI Biomedical Commercialization License Features
Figure 6. Global AI Biomedicine Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global AI Biomedicine Service Market Share by Application: 2024 VS 2031
Figure 8. Oral Preparations Case Studies
Figure 9. Injections Case Studies
Figure 10. Others Case Studies
Figure 11. AI Biomedicine Service Report Years Considered
Figure 12. Global AI Biomedicine Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global AI Biomedicine Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global AI Biomedicine Service Market Share by Region: 2024 VS 2031
Figure 15. Global AI Biomedicine Service Market Share by Players in 2024
Figure 16. Global AI Biomedicine Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by AI Biomedicine Service Revenue in 2024
Figure 18. North America AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America AI Biomedicine Service Market Share by Country (2020-2031)
Figure 20. United States AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe AI Biomedicine Service Market Share by Country (2020-2031)
Figure 24. Germany AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific AI Biomedicine Service Market Share by Region (2020-2031)
Figure 32. China AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America AI Biomedicine Service Market Share by Country (2020-2031)
Figure 40. Mexico AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa AI Biomedicine Service Market Share by Country (2020-2031)
Figure 44. Turkey AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abcellera Biologics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 48. HotSpot Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 49. C4XD Discovery Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 50. Thorne HealthTech Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 51. Scorpion Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 52. Charm Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 53. Evisagenics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 54. Evotec Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 55. PathAI Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 56. Wave Life Sciences Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 57. LifeMine Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 58. PaigeAI Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 59. Westlake Omics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 60. Atomwise Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 61. XtalPi Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 62. IIpharma Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global AI Biomedicine Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AI Biomedical Research And Development
Table 3. Key Players of AI Biomedical Commercialization License
Table 4. Global AI Biomedicine Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global AI Biomedicine Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global AI Biomedicine Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global AI Biomedicine Service Market Share by Region (2020-2025)
Table 8. Global AI Biomedicine Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global AI Biomedicine Service Market Share by Region (2026-2031)
Table 10. AI Biomedicine Service Market Trends
Table 11. AI Biomedicine Service Market Drivers
Table 12. AI Biomedicine Service Market Challenges
Table 13. AI Biomedicine Service Market Restraints
Table 14. Global AI Biomedicine Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global AI Biomedicine Service Market Share by Players (2020-2025)
Table 16. Global Top AI Biomedicine Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Biomedicine Service as of 2024)
Table 17. Ranking of Global Top AI Biomedicine Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by AI Biomedicine Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of AI Biomedicine Service, Headquarters and Area Served
Table 20. Global Key Players of AI Biomedicine Service, Product and Application
Table 21. Global Key Players of AI Biomedicine Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global AI Biomedicine Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global AI Biomedicine Service Revenue Market Share by Type (2020-2025)
Table 25. Global AI Biomedicine Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global AI Biomedicine Service Revenue Market Share by Type (2026-2031)
Table 27. Global AI Biomedicine Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global AI Biomedicine Service Revenue Market Share by Application (2020-2025)
Table 29. Global AI Biomedicine Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global AI Biomedicine Service Revenue Market Share by Application (2026-2031)
Table 31. North America AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America AI Biomedicine Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America AI Biomedicine Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe AI Biomedicine Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe AI Biomedicine Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific AI Biomedicine Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific AI Biomedicine Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific AI Biomedicine Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America AI Biomedicine Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America AI Biomedicine Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa AI Biomedicine Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa AI Biomedicine Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa AI Biomedicine Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abcellera Biologics Company Details
Table 47. Abcellera Biologics Business Overview
Table 48. Abcellera Biologics AI Biomedicine Service Product
Table 49. Abcellera Biologics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 50. Abcellera Biologics Recent Development
Table 51. HotSpot Therapeutics Company Details
Table 52. HotSpot Therapeutics Business Overview
Table 53. HotSpot Therapeutics AI Biomedicine Service Product
Table 54. HotSpot Therapeutics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 55. HotSpot Therapeutics Recent Development
Table 56. C4XD Discovery Company Details
Table 57. C4XD Discovery Business Overview
Table 58. C4XD Discovery AI Biomedicine Service Product
Table 59. C4XD Discovery Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 60. C4XD Discovery Recent Development
Table 61. Thorne HealthTech Company Details
Table 62. Thorne HealthTech Business Overview
Table 63. Thorne HealthTech AI Biomedicine Service Product
Table 64. Thorne HealthTech Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 65. Thorne HealthTech Recent Development
Table 66. Scorpion Therapeutics Company Details
Table 67. Scorpion Therapeutics Business Overview
Table 68. Scorpion Therapeutics AI Biomedicine Service Product
Table 69. Scorpion Therapeutics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 70. Scorpion Therapeutics Recent Development
Table 71. Charm Therapeutics Company Details
Table 72. Charm Therapeutics Business Overview
Table 73. Charm Therapeutics AI Biomedicine Service Product
Table 74. Charm Therapeutics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 75. Charm Therapeutics Recent Development
Table 76. Evisagenics Company Details
Table 77. Evisagenics Business Overview
Table 78. Evisagenics AI Biomedicine Service Product
Table 79. Evisagenics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 80. Evisagenics Recent Development
Table 81. Evotec Company Details
Table 82. Evotec Business Overview
Table 83. Evotec AI Biomedicine Service Product
Table 84. Evotec Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 85. Evotec Recent Development
Table 86. PathAI Company Details
Table 87. PathAI Business Overview
Table 88. PathAI AI Biomedicine Service Product
Table 89. PathAI Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 90. PathAI Recent Development
Table 91. Wave Life Sciences Company Details
Table 92. Wave Life Sciences Business Overview
Table 93. Wave Life Sciences AI Biomedicine Service Product
Table 94. Wave Life Sciences Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 95. Wave Life Sciences Recent Development
Table 96. LifeMine Therapeutics Company Details
Table 97. LifeMine Therapeutics Business Overview
Table 98. LifeMine Therapeutics AI Biomedicine Service Product
Table 99. LifeMine Therapeutics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 100. LifeMine Therapeutics Recent Development
Table 101. PaigeAI Company Details
Table 102. PaigeAI Business Overview
Table 103. PaigeAI AI Biomedicine Service Product
Table 104. PaigeAI Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 105. PaigeAI Recent Development
Table 106. Westlake Omics Company Details
Table 107. Westlake Omics Business Overview
Table 108. Westlake Omics AI Biomedicine Service Product
Table 109. Westlake Omics Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 110. Westlake Omics Recent Development
Table 111. Atomwise Company Details
Table 112. Atomwise Business Overview
Table 113. Atomwise AI Biomedicine Service Product
Table 114. Atomwise Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 115. Atomwise Recent Development
Table 116. XtalPi Company Details
Table 117. XtalPi Business Overview
Table 118. XtalPi AI Biomedicine Service Product
Table 119. XtalPi Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 120. XtalPi Recent Development
Table 121. IIpharma Company Details
Table 122. IIpharma Business Overview
Table 123. IIpharma AI Biomedicine Service Product
Table 124. IIpharma Revenue in AI Biomedicine Service Business (2020-2025) & (US$ Million)
Table 125. IIpharma Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. AI Biomedicine Service Picture
Figure 2. Global AI Biomedicine Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI Biomedicine Service Market Share by Type: 2024 VS 2031
Figure 4. AI Biomedical Research And Development Features
Figure 5. AI Biomedical Commercialization License Features
Figure 6. Global AI Biomedicine Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global AI Biomedicine Service Market Share by Application: 2024 VS 2031
Figure 8. Oral Preparations Case Studies
Figure 9. Injections Case Studies
Figure 10. Others Case Studies
Figure 11. AI Biomedicine Service Report Years Considered
Figure 12. Global AI Biomedicine Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global AI Biomedicine Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global AI Biomedicine Service Market Share by Region: 2024 VS 2031
Figure 15. Global AI Biomedicine Service Market Share by Players in 2024
Figure 16. Global AI Biomedicine Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by AI Biomedicine Service Revenue in 2024
Figure 18. North America AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America AI Biomedicine Service Market Share by Country (2020-2031)
Figure 20. United States AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe AI Biomedicine Service Market Share by Country (2020-2031)
Figure 24. Germany AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific AI Biomedicine Service Market Share by Region (2020-2031)
Figure 32. China AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America AI Biomedicine Service Market Share by Country (2020-2031)
Figure 40. Mexico AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa AI Biomedicine Service Market Share by Country (2020-2031)
Figure 44. Turkey AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE AI Biomedicine Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abcellera Biologics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 48. HotSpot Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 49. C4XD Discovery Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 50. Thorne HealthTech Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 51. Scorpion Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 52. Charm Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 53. Evisagenics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 54. Evotec Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 55. PathAI Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 56. Wave Life Sciences Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 57. LifeMine Therapeutics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 58. PaigeAI Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 59. Westlake Omics Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 60. Atomwise Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 61. XtalPi Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 62. IIpharma Revenue Growth Rate in AI Biomedicine Service Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232